Yu-Wei Chen (Yu Wai Chen)

Years Active: 2020-2021
Publications (10 Years): 5

Hong Kong Polytechnic University

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hong Kong Polytechnic University Aug 22o 2016

Hong Kong

Senior Research Fellow :: Applied Biology & Chemical Technology

Education History

University of Cambridge Oct 1o 1990 - Jul 31o 1994

United Kingdom

PHD :: Chemical Laboratory

Publications

Yu-Wei Chen, Shah Kamranur Rahman
Fatal Attraction: The Case of Toxic Soluble Dimers of Truncated PQBP-1 Mutants in X-Linked Intellectual Disability. International journal of molecular sciences 22 (5) (2021)
Ruo-Lan Du, Ning Sun, Yik-Hong Fung, Yuan-Yuan Zheng, Yu-Wei Chen, Pak-Ho Chan, Wing-Leung Wong, Kwok-Yin Wong
Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism. RSC medicinal chemistry 13 (1) (2021)
Sai-Fung Chung, Chi-Fai Kim, Sui-Yi Kwok, Suet-Ying Tam, Yu-Wei Chen, Hiu-Chi Chong, Siu-Lun Leung, Pui-Kin So, Kwok-Yin Wong, Yun-Chung Leung, Wai-Hung Lo
Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer. International journal of molecular sciences 21 (12) (2020)
Yu-Wei Chen, Chin-Pang Bennu Yiu, Kwok-Yin Wong
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research 9 (2020)
Yu-Wei Chen, Chin-Pang Bennu Yiu, Kwok-Yin Wong
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research (2020)

Yu-Wei Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Yu Wai Chen)